These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 29617302)

  • 21. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
    Santhosh PB; Ulrih NP
    Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons.
    Majidinia M; Mirza-Aghazadeh-Attari M; Rahimi M; Mihanfar A; Karimian A; Safa A; Yousefi B
    IUBMB Life; 2020 May; 72(5):855-871. PubMed ID: 31913572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
    Xue X; Liang XJ
    Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advance on combination therapy strategies based on biomedical nanotechnology induced ferroptosis for cancer therapeutics.
    Chen S; Shi J; Yu D; Dong S
    Biomed Pharmacother; 2024 Jul; 176():116904. PubMed ID: 38878686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
    Cerqueira BB; Lasham A; Shelling AN; Al-Kassas R
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):140-51. PubMed ID: 26515260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition.
    Gupta U; Maity D; Sharma VK
    Biomed Mater; 2023 Nov; 19(1):. PubMed ID: 37944188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN; Shen Q; Li SS
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer chemotherapy with lipid-based nanocarriers.
    Liu D; Zhang N
    Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.
    Yadav P; Ambudkar SV; Rajendra Prasad N
    J Nanobiotechnology; 2022 Sep; 20(1):423. PubMed ID: 36153528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
    Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
    Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of Nano-Drug Delivery System Based on Cascade Technology in Cancer Treatment.
    Sun Y; Ma X; Hu H
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanopreparations to overcome multidrug resistance in cancer.
    Patel NR; Pattni BS; Abouzeid AH; Torchilin VP
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1748-62. PubMed ID: 23973912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glyco-nanoparticles: New drug delivery systems in cancer therapy.
    Khan H; Mirzaei HR; Amiri A; Kupeli Akkol E; Ashhad Halimi SM; Mirzaei H
    Semin Cancer Biol; 2021 Feb; 69():24-42. PubMed ID: 31870939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Nanorobotics-Based Approach of Breast Cancer in the Nanotechnology Era.
    Neagu AN; Jayaweera T; Weraduwage K; Darie CC
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.
    Zamboni WC; Torchilin V; Patri AK; Hrkach J; Stern S; Lee R; Nel A; Panaro NJ; Grodzinski P
    Clin Cancer Res; 2012 Jun; 18(12):3229-41. PubMed ID: 22669131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
    Milane L; Ganesh S; Shah S; Duan ZF; Amiji M
    J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnology-based products for cancer immunotherapy.
    Shams F; Golchin A; Azari A; Mohammadi Amirabad L; Zarein F; Khosravi A; Ardeshirylajimi A
    Mol Biol Rep; 2022 Feb; 49(2):1389-1412. PubMed ID: 34716502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.